| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $156,823,750 ) (Continued on the next page) |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173456 | Microfluidic organoid model of cardio-hepatic physiology and disease | 000 | 1 | NIH | 3/12/2024 | $501,361 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AR082689 | The Epigenetic Regulation of Epidermal Stem Cells in Adult Skin Wound Healing | 001 | 1 | NIH | 3/1/2024 | $0 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AR082689 | The Epigenetic Regulation of Epidermal Stem Cells in Adult Skin Wound Healing | 000 | 1 | NIH | 2/22/2024 | $46,094 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24ES028522 | The Programming Research in Obesity, GRowth, Environment and Social Stress (PROGRESS) Cohort | 000 | 6 | NIH | 3/25/2024 | $394,500 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T32MH135853 | Training Program in Social Neuroscience Research | 000 | 1 | NIH | 3/22/2024 | $131,539 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139631 | Nrf2 and the expansion and preservation of beta cell mass | 000 | 1 | NIH | 3/18/2024 | $770,308 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH132733 | Establishing the Suicide Working Group of the Psychiatric Genomics Consortium to elucidate the genetics and biology of suicide outcomes | 000 | 1 | NIH | 12/6/2023 | $778,716 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK138025 | microRNA-controlled mRNA therapeutics | 000 | 1 | NIH | 3/18/2024 | $559,205 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24NS135391 | New York City Collaborative Regional Coordinating Center (NYCC-RCC) | 000 | 1 | NIH | 12/11/2023 | $495,616 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 000 | 1 | NIH | 3/4/2024 | $588,000 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21NS134158 | Novel mechanisms of confined migration of GBM cells | 000 | 1 | NIH | 4/15/2024 | $223,621 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173203 | The Chromatin Remodeling Factor ARID1a and the Epigenetic Landscape In Pulmonary Arterial Hypertension | 000 | 1 | NIH | 3/4/2024 | $754,967 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21EY035793 | Pre-diagnosis Biomarker Discovery for Age-Related Macular Degeneration | 000 | 1 | NIH | 12/13/2023 | $253,500 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274251 | Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer | 000 | 1 | NIH | 3/5/2024 | $586,431 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21ES035169 | Examining Mitigating Effects of Diet on Associations among Metals and Early Childhood Psychiatric Problems | 000 | 1 | NIH | 2/7/2024 | $268,129 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21ES035169 | Examining Mitigating Effects of Diet on Associations among Metals and Early Childhood Psychiatric Problems | 001 | 1 | NIH | 2/9/2024 | $0 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DC020980 | Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | 000 | 1 | NIH | 12/5/2023 | $731,611 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG065926 | Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease | 000 | 2 | NIH | 3/6/2024 | $756,960 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08DK137022 | Optimizing diabetes treatment strategies in complex comorbidity | 000 | 1 | NIH | 3/7/2024 | $165,714 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG013350 | Systematic integration of variant interpretation tools into genetic and genomic risk prediction | 000 | 1 | NIH | 3/11/2024 | $454,382 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99ES035894 | A Community Partnered Approach to Assessing the Impact of Prenatal Pesticide Exposure on Child Respiratory Outcomes in Mexico City | 000 | 1 | NIH | 3/11/2024 | $105,924 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL171676 | A randomized trial of perception of airflow limitation training to improve outcomes for older adults with asthma | 000 | 1 | NIH | 12/21/2023 | $779,264 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08DA060084 | Cannabinoid Receptor Type 2 Agonist as Potential Therapy for Neuroinflammation in HIV-1 Associated Neurocognitive Disorders | 000 | 1 | NIH | 12/29/2023 | $194,940 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK138369 | The KQ1 serum study: soluble biomarkers for T1D risk, development & progression | 000 | 1 | NIH | 1/30/2024 | $1,230,771 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK137968 | The effects of a high fructose diet on the gut microbiome and metabolic health: A controlled clinical intervention study | 000 | 1 | NIH | 2/7/2024 | $728,243 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS137631 | Myeloid Recruitments and their Role in Brain Tumors | 000 | 1 | NIH | 4/12/2024 | $671,763 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 000 | 1 | NIH | 1/30/2024 | $618,621 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL168897 | Application of Machine Learning to Identify Obstructive Sleep Apnea Subgroups at Risk for Atherosclerosis Progression and Cardiovascular Disease Events (OSA-GRANDE) | 000 | 1 | NIH | 2/21/2024 | $804,477 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03DK138492 | Identification of Novel Regulatory Mechanisms Driving Human beta-Cell Maturation and Function. | 000 | 1 | NIH | 2/26/2024 | $169,000 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI179427 | Harnessing native glycosylation to improve immunogenicity of HIV-1 Env immunogens | 000 | 1 | NIH | 4/16/2024 | $776,402 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23DA058860 | Telehealth to Improve Post-Incarceration Treatment for OUD Patients (TIPTOP): AnAcceptability and Feasibility Trial | 000 | 1 | NIH | 4/12/2024 | $193,940 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K22AI175478 | Roles of immunity to the microbiota in peripheral nerve regeneration and pain sensation. | 000 | 1 | NIH | 4/12/2024 | $162,000 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG082185 | The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease | 000 | 2 | NIH | 1/19/2024 | $1,969,360 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01OH012622 | Racial and Ethnic Disparities in Liver Disease in the WTC General Responder Cohort | 00 | 2 | CDC | 4/10/2024 | $499,995 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01OH012628 | Assessing the impact of WTC dust exposure on prostate cancer recurrence | 00 | 2 | CDC | 4/10/2024 | $499,998 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES034779 | Addressing Community Concerns and Assessing Exposures and Alternatives to Artificial Turf Fields and Playgrounds | 000 | 2 | NIH | 2/26/2024 | $669,992 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | D3349078 | Preventive Medicine Residency | 00 | 2 | HRSA | 3/15/2024 | $147,368 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH133039 | Molecular and functional architecture of a premotor circuit for decision making | 000 | 2 | NIH | 1/22/2024 | $634,808 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA058681 | Enhancement of the endogenous opioid system by ketamine | 000 | 2 | NIH | 4/23/2024 | $557,202 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH132239 | Computational phenotyping of face expression in early psychosis | 000 | 2 | NIH | 1/9/2024 | $616,500 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | P01AI168258 | Targeting trained immunity in transplantation | 000 | 2 | NIH | 4/1/2024 | $3,018,892 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03AG078953 | Translating in vivo drug screens to Alzheimer's patients with a pharmaco-epidemiological approach | 001 | 2 | NIH | 4/19/2024 | $169,000 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173593 | Cardiac AAV gene delivery for clinical translation | 000 | 1 | NIH | 4/2/2024 | $736,718 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173006 | Therapy Development for Genetic Disorders of the RAS/MAPK Pathway | 000 | 1 | NIH | 4/24/2024 | $685,654 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 1 | NIH | 4/4/2024 | $338,000 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01DA059689 | Determining the role of tripartite cell populations in THC-Induced behavioral phenotypes | 000 | 1 | NIH | 3/13/2024 | $180,847 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG087324 | Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease | 000 | 1 | NIH | 4/23/2024 | $572,568 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI183028 | Redox homeostasis to capture regulatory T cell heterogeneity in transplant | 000 | 1 | NIH | 1/17/2024 | $228,150 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA285713 | Mechanisms determining tumor-selective potency of RAS pathway inhibitors | 000 | 1 | NIH | 12/22/2023 | $723,506 |
|